With money still coming in from individual investors, the CEO of Research Triangle Park-based Cloud Pharmaceuticals says he will launch a Series B round with a $10 million target.
Though still small, the company has grown. It has taken in $7 million and now works with 28 employees, including eight full-time staff. Of the money the company has raised, $3 million has been from angel investors, $1 million from the company founders.
The company seeks to identify potential new medicines by targeting…With money still coming in from individual investors, the CEO of Research Triangle Park-based Cloud Pharmaceuticals says he will launch a Series B round with a $10 million target.
Though still small, the company has grown. It has taken in $7 million and now works with 28 employees, including eight full-time staff. Of the money the company has raised, $3 million has been from angel investors, $1 million from the company founders.
The company seeks to identify potential new medicines by targeting…